Literature DB >> 18366963

Management of stroke in cancer.

Lisa R Rogers1.   

Abstract

Cerebrovascular disorders, including brain infarction, brain hemorrhage, and cerebral venous thrombosis, can occur as an early sign of cancer, but typically occur late in the clinical course. These disorders are due to a variety of pathogenic mechanisms, including coagulation disorders associated with the cancer, invasion or compression of vessels from tumor in or adjacent to the brain, and the adverse effects of cancer therapy. The appropriate therapy for these cerebrovascular disorders is empiric in most instances, because as yet there are no prospective treatment trials for them. A review of the existing literature reveals that improvement in patient quality of life and prevention of further cerebrovascular events can be obtained in some clinical situations.

Entities:  

Mesh:

Year:  2008        PMID: 18366963     DOI: 10.1007/s11912-008-0011-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  45 in total

1.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis.

Authors:  K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

2.  Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.

Authors:  Maurilio Ponzoni; Andrés J M Ferreri; Elías Campo; Fabio Facchetti; Luca Mazzucchelli; Tadashi Yoshino; Takuhei Murase; Stefano A Pileri; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Shigeo Nakamura
Journal:  J Clin Oncol       Date:  2007-06-18       Impact factor: 44.544

3.  Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases.

Authors:  P Klein; E C Haley; G F Wooten; S R VandenBerg
Journal:  Arch Neurol       Date:  1989-10

4.  Loco-regional thrombolysis in the treatment of cerebral venous and sinus thrombosis: report of two cases.

Authors:  G Buccino; U Scoditti; M Pini; R Menozzi; P Piazza; P Zuccoli; D Mancia
Journal:  Acta Neurol Scand       Date:  2001-01       Impact factor: 3.209

5.  Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients.

Authors:  L F Bleggi-Torres; B Werner; E L Gasparetto; B C de Medeiros; R Pasquini; C R de Medeiros
Journal:  Bone Marrow Transplant       Date:  2002-01       Impact factor: 5.483

6.  Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients.

Authors:  J J Raizer; L M DeAngelis
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

Review 7.  Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.

Authors:  L I Gordon; H C Kwaan
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

8.  CNS angiitis in graft vs host disease.

Authors:  M Ma; G Barnes; J Pulliam; D Jezek; R J Baumann; J R Berger
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

9.  Cerebral infarction as a result of tumor emboli.

Authors:  B P O'Neill; R P Dinapoli; H Okazaki
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860

Review 10.  Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Managing the problem of hyperleukocytosis in acute leukemia.

Authors:  A R Ablin
Journal:  Am J Pediatr Hematol Oncol       Date:  1984
View more
  3 in total

Review 1.  Neurologic complications of cancer and its treatment.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

2.  Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series.

Authors:  S Iurlaro; A Silvani; M Mauri; G Truci; S Beretta; A Zilioli; M Guidotti; A Salmaggi; C Ferrarese; G Comi; M Riva
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

3.  Intracranial hemorrhage in adult patients with hematological malignancies.

Authors:  Chien-Yuan Chen; Chan-Hwei Tai; Aristine Cheng; Hung-Chang Wu; Woei Tsay; Jia-Hau Liu; Pey-Ying Chen; Shang-Yi Huang; Ming Yao; Jih-Luh Tang; Hwei-Fang Tien
Journal:  BMC Med       Date:  2012-08-29       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.